WU Yingying, ZHANG Guoxing, LIU Di, TIAN Lili, ZHOU Guanhua, LIAO Wenqi, DAI Bin, CHEN Jingwei. Intervention of tiaozhi granules on autophagy of HUVECs[J]. Journal of Clinical Medicine in Practice, 2017, (5): 49-53. DOI: 10.7619/jcmp.201705014
Citation: WU Yingying, ZHANG Guoxing, LIU Di, TIAN Lili, ZHOU Guanhua, LIAO Wenqi, DAI Bin, CHEN Jingwei. Intervention of tiaozhi granules on autophagy of HUVECs[J]. Journal of Clinical Medicine in Practice, 2017, (5): 49-53. DOI: 10.7619/jcmp.201705014

Intervention of tiaozhi granules on autophagy of HUVECs

More Information
  • Objective To investigate the effect of tiaozhi granules on the autophagy of HU-VECs in the cell,protein and molecular levels.Methods HUVECs were induced by tiaozhi granule medicated serum,6-amino-3-methyl purine (3-MA) and rapamycin.MTT was used to detect the cell viability after 48 hours with tiaozhi granule medicated serum.Western blot was used to detect the expressive level of LC3-Ⅱ.Immunofluorescence was used to detect change in the numbers of autophagosomes.Results After HUVECs was processed by tiaozhi granule medicated serum,the cell viability had not change,the relative expression of autophagy related protein LC3-Ⅱ increased,and the number of autophagosomes increased (P < 0.05).After HUVECs was processed by tiaozhi granule medicated serum and rapamycin,cell viability had no change,while the relative expression of autophagy related protein LC3-Ⅱ and the number of autophagosomes decreased significantly when compared with the results of intervention with rapamycin only (P < 0.05 or P < 0.01).Conclusion Tiaozhi granules can inhibit excessive autophagy of endothelial cells and promote moderate autophagy in endothelial cells.
  • Related Articles

    [1]ZHANG Shuyuan, HUANG Yongtao, YU Wenjin. Relationship between non-high-density lipoprotein cholesterol and cardiovascular disease in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 106-111. DOI: 10.7619/jcmp.20244504
    [2]LU Chang, ZHANG Ying, WU Fangqin, ZOU Yingbin. Related factors of implementation status of cardiac rehabilitation by nurses in cardiovascular departments[J]. Journal of Clinical Medicine in Practice, 2024, 28(22): 115-118, 122. DOI: 10.7619/jcmp.20242872
    [3]LU Bing, WANG Qianqian, ZHONG Shao. A cohort study of atherogenic index of plasma and the risk of cardiovascular disease in community elderly hypertensive population of Kunshan area[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 54-58. DOI: 10.7619/jcmp.20240954
    [4]LIU Yuan, ZHANG Hongjin, LIU Jia. Prognostic value of serum fibroblast growth factor 23 and S100A12 for atherosclerosis cardiovascular disease in elderly patients with diabetes[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 99-103. DOI: 10.7619/jcmp.20233072
    [5]XU Peng, BIAN Xinghua, WANG Yuhang. Effects of adipokines, inflammatory factors and intestinal flora on major adverse cardiovascular events in patients with coronary heart disease after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2023, 27(13): 81-86. DOI: 10.7619/jcmp.20231409
    [6]ZHOU Wei, DENG Yifan, ZHANG Jing. Effect of uric acid lowering therapy on content of endothelial microparticles in peripheral blood and major adverse cardiovascular events in patients with gout complicated with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 60-63. DOI: 10.7619/jcmp.20223021
    [7]SHEN Jing, HUANG Wenjun, NIU Lijian, MA Yongxiang, ZHANG Jing. Research on mechanism of exercise rehabilitation therapy in cardiovascular diseases[J]. Journal of Clinical Medicine in Practice, 2021, 25(15): 124-127. DOI: 10.7619/jcmp.20211454
    [8]ZHU Yuqin, GUO Kai. Research progress of cardiovascular benefits patients treated by gucagon like peptide-1 receptor agonists[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 107-110. DOI: 10.7619/jcmp.20200711
    [9]DU Wenjie, GAO Chunhong, HU Xiaolin, TANG Yifan. Analysis on influencing factors of severity of comorbidities and quality of life in elderly patients with cardiovascular disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 51-54. DOI: 10.7619/jcmp.202012015
    [10]QIU Ning, LI Jinhua, HUANG Wenjing. Role of HbA1c level in predicting cardiovascular diseases in elderly patients with diabetes[J]. Journal of Clinical Medicine in Practice, 2016, (9): 26-28. DOI: 10.7619/jcmp.201609007
  • Cited by

    Periodical cited type(4)

    1. 梁国强,葛惠男,章一凡,欧阳八四,郭金伟,孙柳,杰辉,龚诚,沈贤敏,朱慧,沈为濂,朱惠萍. 吴门调脂颗粒方对非酒精性脂肪肝大鼠肝组织NF-κBp65/P38MAPK蛋白表达的影响. 亚太传统医药. 2021(05): 19-23 .
    2. 吴瑛滢,张国兴,陈竞纬. 吴门调脂颗粒对大鼠平滑肌细胞自噬的干预研究. 中医药导报. 2020(12): 19-23 .
    3. 王峥嵘,范焕芳,张倩,郭洁,李德辉. β-榄香烯阻断JAK2-STAT3信号通路促进紫杉醇对肺癌细胞增殖和凋亡作用研究. 中华中医药学刊. 2019(07): 1600-1604 .
    4. 陈超,赵笑东,张国兴,尹学敏,陈竞纬. 调脂颗粒干预血管紧张素Ⅱ诱导内皮细胞自噬水平的实验研究. 中国中医急症. 2018(05): 753-756+760 .

    Other cited types(0)

Catalog

    Article views (260) PDF downloads (5) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return